UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CT-based muscle and adipose measurements predict prognosis in patients with digestive system malignancy

Scientific reports, 2024-06, Vol.14 (1), p.13036-13

2024

Volltextzugriff (PDF)

CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

Cancers, 2021-04, Vol.13 (8), p.1955

2021

Volltextzugriff (PDF)

Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients

Molecular and clinical oncology, 2017-09, Vol.7 (3), p.498-506

2017

Volltextzugriff (PDF)

Nutritional features-based clustering analysis as a feasible approach for early identification of malnutrition in patients with cancer

European journal of clinical nutrition, 2021-08, Vol.75 (8), p.1291-1301

2021

Volltextzugriff (PDF)

Development and validation of an inflammatory biomarkers model to predict gastric cancer prognosis: a multi-center cohort study in China

BMC cancer, 2024-06, Vol.24 (1), p.1-13

2024

Volltextzugriff (PDF)

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists

Journal of translational medicine, 2023-02, Vol.21 (1), p.108-108, Article 108

2023

Volltextzugriff (PDF)

Mid-Arm Muscle Circumference or Body Weight-Standardized Hand Grip Strength in the GLIM Superiorly Predicts Survival in Chinese Colorectal Cancer Patients

Nutrients, 2022-12, Vol.14 (23), p.5166

2022

Volltextzugriff (PDF)

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events

Cancer biology & medicine, 2021-11, Vol.18 (4), p.1118-1133

2021

Volltextzugriff (PDF)

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

BMC cancer, 2021-01, Vol.21 (1), p.56-56, Article 56

2021

Volltextzugriff (PDF)

Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations

Therapeutic Advances in Medical Oncology, 2023-01, Vol.15, p.17588359231187205-17588359231187205

2023

Volltextzugriff (PDF)

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003214

2021

Volltextzugriff (PDF)

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non‐small‐cell lung cancer who have progressed after anti‐PD‐1/L1 therapy

Cancer medicine (Malden, MA), 2024-02, Vol.13 (3), p.e6855-n/a

2024

Volltextzugriff (PDF)

A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice

Open medicine (Warsaw, Poland), 2022-01, Vol.17 (1), p.53-60

2022

Volltextzugriff (PDF)

Triceps skinfold–albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study

Journal of cachexia, sarcopenia and muscle, 2023-02, Vol.14 (1), p.517-533

2023

Volltextzugriff (PDF)

SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

Journal for immunotherapy of cancer, 2023-02, Vol.11 (2), p.e006055

2023

Volltextzugriff (PDF)

Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial

Signal transduction and targeted therapy, 2024-09, Vol.9 (1), p.248-9, Article 248

2024

Volltextzugriff (PDF)

Zinc deficiency exacerbates diabetic down-regulation of Akt expression and function in the testis: essential roles of PTEN, PTP1B and TRB3

The Journal of nutritional biochemistry, 2012-08, Vol.23 (8), p.1018-1026

2012

Volltextzugriff (PDF)

High Visceral Fat in Female Breast Cancer Patients Correlates with the Risk of Progression after Adjuvant Chemotherapy

Nutrition and cancer, 2022-07, Vol.74 (6), p.2038-2048

2022

Volltextzugriff (PDF)

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial

The lancet oncology, 2022-02, Vol.23 (2), p.220-233

2022

Volltextzugriff (PDF)

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-09, Vol.328 (12), p.1223

2022

Volltextzugriff (PDF)

The clinical application value of the extracellular-water-to-total-body-water ratio obtained by bioelectrical impedance analysis in people with advanced cancer

Nutrition (Burbank, Los Angeles County, Calif.), 2022-04, Vol.96, p.111567-111567, Article 111567

2022

Volltextzugriff (PDF)

New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism

Drug design, development and therapy, 2022-08, Vol.16, p.2497-2507

2022

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

SpracheChinesisch

ThemaPatients

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CT-based muscle and adipose measurements predict prognosis in patients with digestive system malignancy

CAR-T in Cancer Treatment: Develop in Self-Optimization, Win-Win in Cooperation

Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: A meta-analysis of 7,219 patients

Nutritional features-based clustering analysis as a feasible approach for early identification of malnutrition in patients with cancer

Development and validation of an inflammatory biomarkers model to predict gastric cancer prognosis: a multi-center cohort study in China

BAX as the mediator of C-MYC sensitizes acute lymphoblastic leukemia to TLR9 agonists

Mid-Arm Muscle Circumference or Body Weight-Standardized Hand Grip Strength in the GLIM Superiorly Predicts Survival in Chinese Colorectal Cancer Patients

Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol

Chinese expert consensus recommendations for the administration of immune checkpoint inhibitors to special cancer patient populations

Genomic alterations in biliary tract cancer predict prognosis and immunotherapy outcomes

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non‐small‐cell lung cancer who have progressed after anti‐PD‐1/L1 therapy

A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice

Triceps skinfold–albumin index significantly predicts the prognosis of cancer cachexia: A multicentre cohort study

SAFFRON-103: a phase 1b study of the safety and efficacy of sitravatinib combined with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer

Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial

Zinc deficiency exacerbates diabetic down-regulation of Akt expression and function in the testis: essential roles of PTEN, PTP1B and TRB3

High Visceral Fat in Female Breast Cancer Patients Correlates with the Risk of Progression after Adjuvant Chemotherapy

Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study

Sugemalimab versus placebo, in combination with platinum-based chemotherapy, as first-line treatment of metastatic non-small-cell lung cancer (GEMSTONE-302): interim and final analyses of a double-blind, randomised, phase 3 clinical trial

Sugemalimab versus placebo after concurrent or sequential chemoradiotherapy in patients with locally advanced, unresectable, stage III non-small-cell lung cancer in China (GEMSTONE-301): interim results of a randomised, double-blind, multicentre, phase 3 trial

Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial

The clinical application value of the extracellular-water-to-total-body-water ratio obtained by bioelectrical impedance analysis in people with advanced cancer

Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial

New Oral Anticoagulants Open New Horizons for Cancer Patients with Venous Thromboembolism

Aktive Filter

Suchergebnisse filtern